创模生物科技(北京)有限公司

CN / En

NEWS

In Vitro Killing Experiment Platform of InnoModels Biotechnology

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-10-09 16:15
  • Views:

(Summary description)In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.

In Vitro Killing Experiment Platform of InnoModels Biotechnology

(Summary description)In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-10-09 16:15
  • Views:
Information

In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
Overview of InnoModels Biocidal Experimental Platform
As a biotech company co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion and Shanghai Jiao Tong University Institute of Immunology, InnoModels Biotechnology (Beijing) Co., Ltd. is noteworthy for its innovative practices in the field of life sciences. The company not only owns a stable domestic platform for humanized mouse models of the immune system (HIS) and a platform for human-derived tumor xenografts (PDX), but also devotes itself to building an efficient and precise platform for in vitro killing experiments, which can provide powerful support for the research and development of new drugs and cellular mechanisms.
Platform Features
1、Highly controllable experimental environment: InnoModels' in vitro killing experimental platform provides the ability to precisely control the experimental conditions, such as temperature, humidity, and atmosphere, to ensure the accuracy and reproducibility of the experimental results. This highly controllable environment provides researchers with a stable and reliable experimental platform, allowing cell killing experiments to be conducted under optimal conditions.
2、 Support for multiple cell types: The platform supports the application of multiple cell types, including tumor cells, primary cells, etc., which meets the diverse needs of researchers in different fields. 
This flexibility enables researchers to carry out in-depth cell killing experiments in a wide range of fields and promote the progress of scientific research.
3、Real-time monitoring and data analysis: During the experimental process, the platform is able to monitor the cell status and response in real time, and at the same time record and analyze the data.  
This real-time feedback mechanism provides researchers with comprehensive experimental results, helping them to more accurately understand the cell killing mechanism and drug action effects.
4、Automation technology application: Thermo Scientific's in vitro cell-killing experimental platform adopts advanced automation technology, which significantly improves the efficiency of the experimental process and reduces the errors caused by human operation.  
The application of this technology not only improves the reliability of experiments, but also allows researchers to focus more on experimental design and data analysis.

 


Application Areas
1、 drug screening: researchers can use the platform for large-scale drug screening to assess the killing effect of drugs on cells.   
This helps to rapidly screen drug candidates with potential therapeutic effects, providing strong support for drug development.
2、Toxicity assessment: The platform can also be used to assess the toxicity level of compounds or drugs, providing important data for safety assessment during drug development.   
This is important to ensure the safety of drugs in clinical trials.
3、Immunotherapy research: In the study of immunotherapy, the platform can be used to assess the killing effect of immune cells on tumor cells.    
This assessment helps to gain a deeper understanding of the mechanisms and effects of immunotherapy, providing a scientific basis for clinical application.
Conclusion
With its unique technical advantages and wide application prospects, the InnoModels Bioin vitro killing experimental platform shows great potential in the field of life sciences. The platform not only provides researchers with efficient and precise experimental tools, but also promotes the in-depth development of drug development and cell mechanism research. In the future, with the continuous progress of the technology and the expansion of the application, InnoModels in vitro killing experimental platform will certainly play an even more important role in the field of life sciences.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司